Tekmira Pharmaceuticals shares rose by 20% on Monday after gaining more than 45% on Friday after the FDA loosened the hold on the treatment of Ebola in the development stage company.
After closing on Thursday afternoon at $ 14.27 per share, the shares of Tekmira traded north of $ 25 on Monday. After gaining more than 45% on Friday
In a press release on Thursday evening, Tekmira said: The US Food and Drug Administration (FDA) has verbally confirmed that they have changed the complete clinical suspended for TKM-Ebola Investigation New Drug Application (IND) to the partial clinical hold. This action allows the potential TKM-Ebola use in persons infected with the Ebola virus. "
Over the weekend, the report of The New York Times said that health workers in Nigeria have confirmed 10 cases and two deaths from Ebola. Nigeria is the most populous country on the continent. Total deaths related to Ebola virus now has more than 900.
The New York Times' also addressed the epidemic of Ebola in these weekends. They wrote that after the who Director-General Margaret Chan called the outbreak, "the largest and most serious, most difficult outbreak" of the virus in its 40-year history "And the world is done in the 40 years to protect against disease? A little. In addition to causing enormous loss of human life, the spread of the Ebola virus in West Africa exposed the unpreparedness of the United States and other developed countries, to protect and treat thousands of Africans whose lives are threatened by extremely dangerous virus, for which there is no cure.
No comments:
Post a Comment